IGC Pharma, Inc. (IGC)
0.3063
0.00 (0.00%)
USD |
NYAM |
Aug 26, 16:00
0.3063
0.00 (0.00%)
After-Hours: 16:22
IGC Pharma Gross Profit Margin (Quarterly) : 2.64% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.64% |
| March 31, 2026 | 4.10% |
| December 31, 2025 | -1.71% |
| September 30, 2025 | -3.14% |
| June 30, 2025 | 8.23% |
| March 31, 2025 | 1.73% |
| December 31, 2024 | |
| September 30, 2024 | 12.86% |
| June 30, 2024 | 7.72% |
| March 31, 2024 | 8.47% |
| December 31, 2023 | -3.43% |
| September 30, 2023 | 11.68% |
| June 30, 2023 | 21.26% |
| March 31, 2023 | -42.77% |
| December 31, 2022 | -16.87% |
| September 30, 2022 | -10.40% |
| June 30, 2022 | -4.72% |
| March 31, 2022 | -108.2% |
| December 31, 2021 | -38.73% |
| September 30, 2021 | -212.5% |
| June 30, 2021 | -163.6% |
| March 31, 2021 | -164.2% |
| December 31, 2020 | -101.9% |
| September 30, 2020 | -62.40% |
| June 30, 2020 | -4.79% |
| Date | Value |
|---|---|
| March 31, 2020 | -189.7% |
| December 31, 2019 | 1.40% |
| September 30, 2019 | 0.22% |
| June 30, 2019 | 1.46% |
| March 31, 2019 | 1.75% |
| December 31, 2018 | 2.41% |
| September 30, 2018 | 0.44% |
| June 30, 2018 | 1.84% |
| March 31, 2018 | -7.01% |
| December 31, 2017 | 4.46% |
| September 30, 2017 | 28.90% |
| June 30, 2017 | 75.80% |
| March 31, 2017 | 3.10% |
| December 31, 2016 | -27.20% |
| September 30, 2016 | -16.15% |
| June 30, 2016 | -3.81% |
| March 31, 2016 | -0.99% |
| December 31, 2015 | 5.79% |
| September 30, 2015 | 0.83% |
| June 30, 2015 | 2.59% |
| March 31, 2015 | -8.91% |
| December 31, 2014 | 1.79% |
| September 30, 2014 | 1.23% |
| June 30, 2014 | -9.46% |
| March 31, 2014 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 88.57% |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 95.92% |
| Fulcrum Therapeutics, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -116.5% |
| Return on Assets | -85.56% |
| Return on Invested Capital | -108.4% |
| Profit Margin (Quarterly) | -1.11K% |
| Operating Margin (Quarterly) | -1.05K% |
| Return on Net Operating Assets | -102.0% |